CRISPR-Cas 9 and Gene Editing
“CRISPR” (pronounced as “Crisper”) is an acronym for Clustered Regularly Interspaced Short Palindromic Repeats. The functions of CRISPR and CRISPR-associated (Cas) genes are the hallmark of a bacterial defence system that are essential in adaptive immunity in select bacteria and archaea. These sequences enable the host organisms to respond to and neutralize invading genetic material. “CRISPR” or “CRISPR-Cas9” is often used (inaccurately) to refer to the different CRISPR-Cas9 and other systems that can be programmed to edit DNA at precise locations. It can also be used for other purposes, such as new diagnostic tools. With these systems, genes can be permanently modified in living cells and organisms. It may be possible, in the future, to correct mutations at precise locations in the human genome for the treatment of genetic disease.
- Genome engineering
- RNA editing
- CRISPR in Cancer
- In vivo applications
Related Conference of CRISPR-Cas 9 and Gene Editing
21th World Congress on Tissue Engineering Regenerative Medicine and Stem Cell Research
16th International Conference on Human Genetics and Genetic Diseases
19th International Conference on Genomics & Pharmacogenomics
CRISPR-Cas 9 and Gene Editing Conference Speakers
Recommended Sessions
- Animal Biotechnology
- Applied Biotechnology
- Biochemistry
- Bioinformatics
- Cancer Biotechnology
- Cell Biology
- CRISPR-Cas 9 and Gene Editing
- Gene and Cellular Therapies
- Genetic Engineering
- Genomics
- Immunology
- Industrial and Environmental Biotechnology
- Metabolic Engineering
- Microbiology
- Molecular Biology and Genetics
- Nanobiotechnology
- Plant Biotechnology
- Protein Engineering
- Stem Cells and Regenerative Medicine
- Tissue Engineering
Related Journals
Are you interested in
- Artificial Intelligence and Computational Biology in Regenerative Medicine - Stemgen 2026 (Japan)
- Biomaterials and Nanotechnology in Regenerative Medicine - Stemgen 2026 (Japan)
- Cancer Stem Cells and Oncology - Stemgen 2026 (Japan)
- Cardiovascular Regeneration - Stemgen 2026 (Japan)
- Clinical Trials and Translational Stem Cell Research - Stemgen 2026 (Japan)
- Ethical, Legal, and Social Implications in Stem Cell Research - Stemgen 2026 (Japan)
- Future Trends: Organoids, Bioengineering, and Next-Generation Therapies - Stemgen 2026 (Japan)
- Gene Editing and CRISPR Technologies - Stemgen 2026 (Japan)
- Induced Pluripotent Stem Cells (iPSCs) and Reprogramming - Stemgen 2026 (Japan)
- Mesenchymal Stem Cells (MSCs) in Therapy - Stemgen 2026 (Japan)
- Regenerative Dentistry and Craniofacial Applications - Stemgen 2026 (Japan)
- Regenerative Medicine and Tissue Engineering - Stemgen 2026 (Japan)
- Stem Cell Banking and Cryopreservation - Stemgen 2026 (Japan)
- Stem Cell Biology and Cellular Mechanisms - Stemgen 2026 (Japan)
- Stem Cells in Neurological and Neurodegenerative Disorders - Stemgen 2026 (Japan)
